Enzim Devi Novonesis Penalized for Competition Violations

Novonesis Group is facing severe penalties for abusing its dominant position in the industrial enzyme market in violation of competition regulations. The Competition Authority has detected the company’s exclusionary commercial practices against its competitors and has imposed an administrative fine of approximately 285 million TL on Novonesis.

Investigations revealed that Novonesis engaged in practices that undermined the genuine competitive environment in the market. The company consistently provided guarantees to its customers for prices significantly better than its rivals while also offering additional discounts for bulk purchases. However, this was not only a financial incentive but also aimed at eroding the market shares of competing firms.

The Competition Authority emphasized that Novonesis imposed the condition of not purchasing rival products through its practices. In this context, the company’s commercial strategies aim to weaken the ability of other firms in the sector to exist in the market. Such practices, carried out in violation of the fundamental principles of competition law, threaten not only a company’s profits but also the overall dynamism of the sector.

Although the industrial enzyme sector is rapidly growing worldwide, maintaining its competitive structure is of great importance. The penalty imposed on Novonesis is indicative of how closely movements and competition policies are monitored. These types of sanctions will also serve as a warning to other players in the sector, as a healthy competitive environment is crucial for both consumer benefits and the sustainability of the market.